GHRL and cancer: Additional large-scale prospective clinical trials are warranted to further elucidate the effects of ghrelin on tumors and general activity in various cancer states, and to evaluate the safety and benefits of ghrelin/ghrelin-receptor agonist treatment in patients with cancer.